WHO discontinues hydroxychloroquine and lopinavir/ritonavir treatment trials for COVID-19

Interim trial results show that hydroxychloroquine and lopinavir/ritonavir produce little or no reduction in the mortality of hospitalised COVID-19 patients.

Please sign in or register for FREE

No comments yet.